Gain Therapeutics, Inc.GANXNASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank57
3Y CAGR-17.2%
5Y CAGR+125.7%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
-17.2%/yr
Annual compound
5Y CAGR
+125.7%/yr
Recent deceleration
Percentile
P57
Within normal range
vs 5Y Ago
58.5x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$212912.00-40.4%
2024$357096.00-27.7%
2023$494234.00+31.7%
2022$375357.00+2904.1%
2021$12495.00+243.6%
2020$3637.00-
2019$0.00-
2018$0.00-